Unknown

Dataset Information

0

Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer.


ABSTRACT: EgKI-1, a member of the Kunitz type protease inhibitor family, is highly expressed by the oncosphere of the canine tapeworm Echinococcus granulosus, the stage that is infectious to humans and ungulates, giving rise to a hydatid cyst localized to the liver and other organs. Larval protoscoleces, which develop within the hydatid cyst, have been shown to possess anti-cancer properties, although the precise molecules involved have not been identified. We show that recombinant EgKI-1 inhibits the growth and migration of a range of human cancers including breast, melanoma and cervical cancer cell lines in a dose-dependent manner in vitro without affecting normal cell growth. Furthermore, EgKI-1 treatment arrested the cancer cell growth by disrupting the cell cycle and induced apoptosis of cancer cells in vitro. An in vivo model of triple negative breast cancer (MDA-MB-231) in BALB/c nude mice showed significant tumor growth reduction in EgKI-1-treated mice compared with controls. These findings indicate that EgKI-1 shows promise for future development as an anti-cancer therapeutic.

SUBMITTER: Ranasinghe SL 

PROVIDER: S-EPMC6118354 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer.

Ranasinghe Shiwanthi L SL   Boyle Glen M GM   Fischer Katja K   Potriquet Jeremy J   Mulvenna Jason P JP   McManus Donald P DP  

PloS one 20180831 8


EgKI-1, a member of the Kunitz type protease inhibitor family, is highly expressed by the oncosphere of the canine tapeworm Echinococcus granulosus, the stage that is infectious to humans and ungulates, giving rise to a hydatid cyst localized to the liver and other organs. Larval protoscoleces, which develop within the hydatid cyst, have been shown to possess anti-cancer properties, although the precise molecules involved have not been identified. We show that recombinant EgKI-1 inhibits the gro  ...[more]

Similar Datasets

| S-EPMC6838156 | biostudies-literature
| S-EPMC4672886 | biostudies-literature
| S-EPMC4464875 | biostudies-literature
| S-EPMC8684439 | biostudies-literature
| S-EPMC2740865 | biostudies-literature
| S-EPMC5998577 | biostudies-literature
| S-EPMC5756312 | biostudies-literature
| S-EPMC4870292 | biostudies-literature
| S-EPMC6838133 | biostudies-literature
| S-EPMC7553295 | biostudies-literature